Skip to content

Title 42 — The Public Health and Welfare

Part B · Chapter 6A — Public Health Service

§ 284l. Enhancement awards

Statutory text

(a)

Mentored Patient-Oriented Research Career Development Awards

(1)

Grants

(A)

In general

The Director of the National Institutes of Health shall make grants (to be referred to as “Mentored Patient-Oriented Research Career Development Awards”) to support individual careers in clinical research at general clinical research centers or at other institutions that have the infrastructure and resources deemed appropriate for conducting patient-oriented clinical research.

(B)

Use

Grants under subparagraph (A) shall be used to support clinical investigators in the early phases of their independent careers by providing salary and such other support for a period of supervised study.

(2)

Applications

An application for a grant under this subsection shall be submitted by an individual scientist at such time as the Director may require.

(b)

Mid-Career Investigator Awards in Patient-Oriented Research

(1)

Grants

(A)

In general

The Director of the National Institutes of Health shall make grants (to be referred to as “Mid-Career Investigator Awards in Patient-Oriented Research”) to support individual clinical research projects at general clinical research centers or at other institutions that have the infrastructure and resources deemed appropriate for conducting patient-oriented clinical research.

(B)

Use

Grants under subparagraph (A) shall be used to provide support for mid-career level clinicians to allow such clinicians to devote time to clinical research and to act as mentors for beginning clinical investigators.

(2)

Applications

An application for a grant under this subsection shall be submitted by an individual scientist at such time as the Director requires.

(c)

Graduate Training in Clinical Investigation Award

(1)

In general

The Director of the National Institutes of Health shall make grants (to be referred to as “Graduate Training in Clinical Investigation Awards”) to support individuals pursuing master’s or doctoral degrees in clinical investigation.

(2)

Applications

An application for a grant under this subsection shall be submitted by an individual scientist at such time as the Director may require.

(3)

Limitations

Grants under this subsection shall be for terms of 2 years or more and shall provide stipend, tuition, and institutional support for individual advanced degree programs in clinical investigation.

(4)

Definition

As used in this subsection, the term “advanced degree programs in clinical investigation” means programs that award a master’s or Ph.D. degree in clinical investigation after 2 or more years of training in areas such as the following:

(A)

Analytical methods, biostatistics, and study design.

(B)

Principles of clinical pharmacology and pharmacokinetics.

(C)

Clinical epidemiology.

(D)

Computer data management and medical informatics.

(E)

Ethical and regulatory issues.

(F)

Biomedical writing.

(d)

Clinical Research Curriculum Awards

(1)

In general

The Director of the National Institutes of Health shall make grants (to be referred to as “Clinical Research Curriculum Awards”) to institutions for the development and support of programs of core curricula for training clinical investigators, including medical students. Such core curricula may include training in areas such as the following:

(A)

Analytical methods, biostatistics, and study design.

(B)

Principles of clinical pharmacology and pharmacokinetics.

(C)

Clinical epidemiology.

(D)

Computer data management and medical informatics.

(E)

Ethical and regulatory issues.

(F)

Biomedical writing.

(2)

Applications

An application for a grant under this subsection shall be submitted by an individual institution or a consortium of institutions at such time as the Director may require. An institution may submit only one such application.

(3)

Limitations

Grants under this subsection shall be for terms of up to 5 years and may be renewable.

Legislative history

Reconstructed from this section’s Code source credit and amendment notes, resolved against the local Statutes at Large. Editorial notes are evidence, not the law that made the change.

  1. Pub. L. 106–505 title II § 204(b) · 114 Stat. 2314

    Enacted · 42 U.S.C. § 284l

    July 1, 1944, ch. 373, title IV, § 409H, formerly § 409D, as added Pub. L. 106–505, title II, § 204(b), Nov. 13, 2000, 114 Stat. 2327

    Source evidence

    Code source credit
    July 1, 1944, ch. 373, title IV, § 409H, formerly § 409D, as added Pub. L. 106–505, title II, § 204(b), Nov. 13, 2000, 114 Stat. 2327

    Enacted provision · exact public law section
    (b) Enhancement Awards.— Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.), as amended by section 203, is further amended by adding at the end the following: “SEC. 409D. ENHANCEMENT AWARDS. “(a) Mentored Patient-Oriented Research Career Development Awards.— “(1) Grants.— “(A) In general.— The Director of the National Institutes of Health shall make grants (to be referred to as ‘Mentored Patient-Oriented Research Career Development Awards’) to support individual careers in clinical research at general clinical research centers or at other institutions that have the infrastructure and resources deemed appropriate for conducting patient-oriented clinical research. “(B) Use.— Grants under subparagraph (A) shall be used to support clinical investigators in the early phases of their independent careers by providing salary and such other support for a period of supervised study. “(2) Applications.— An application for a grant under this subsection shall be submitted by an individual scientist at such time as the Director may require. “(3) Authorization of appropriations.— For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year. “(b) Mid-Career Investigator Awards in Patient-Oriented Research.— “(1) Grants.— “(A) In general.— The Director of the National Institutes of Health shall make grants (to be referred to as ‘Mid-Career Investigator Awards in Patient-Oriented Research’) to support individual clinical research projects at general clinical research centers or at other institutions that have the infrastructure and resources deemed appropriate for conducting patient-oriented clinical research. “(B) Use.— Grants under subparagraph (A) shall be used to provide support for mid-career level clinicians to allow such clinicians to devote time to clinical research and to act as mentors for beginning clinical investigators. “(2) Applications.— An application for a grant under this subsection shall be submitted by an individual scientist at such time as the Director requires. “(3) Authorization of appropriations.— For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year. “(c) Graduate Training in Clinical Investigation Award.— “(1) In general.— The Director of the National Institutes of Health shall make grants (to be referred to as ‘Graduate Training in Clinical Investigation Awards’) to support individuals pursuing master’s or doctoral degrees in clinical investigation. “(2) Applications.— An application for a grant under this subsection shall be submitted by an individual scientist at such time as the Director may require. “(3) Limitations.— Grants under this subsection shall be for terms of 2 years or more and shall provide stipend, tuition, and institutional support for individual advanced degree programs in clinical investigation. “(4) Definition.— As used in this subsection, the term ‘advanced degree programs in clinical investigation’ means programs that award a master’s or Ph.D. degree in clinical investigation after 2 or more years of training in areas such as the following: “(A) Analytical methods, biostatistics, and study design. “(B) Principles of clinical pharmacology and pharmacokinetics. “(C) Clinical epidemiology. “(D) Computer data management and medical informatics. “(E) Ethical and regulatory issues. “(F) Biomedical writing. “(5) Authorization of Appropriations.— For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year. “(d) Clinical Research Curriculum Awards.— “(1) In general.— The Director of the National Institutes of Health shall make grants (to be referred to as ‘Clinical Research Curriculum Awards’) to institutions for the development and support of programs of core curricula for training clinical investigators, including medical students. Such core curricula may include training in areas such as the following: “(A) Analytical methods, biostatistics, and study design. “(B) Principles of clinical pharmacology and pharmacokinetics. “(C) Clinical epidemiology. “(D) Computer data management and medical informatics. “(E) Ethical and regulatory issues. “(F) Biomedical writing. “(2) Applications.— An application for a grant under this subsection shall be submitted by an individual institution or a consortium of institutions at such time as the Director may require. An institution may submit only one such application. “(3) Limitations.— Grants under this subsection shall be for terms of up to 5 years and may be renewable. “(4) Authorization of appropriations.— For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.

  2. National Institutes of Health Reform Act of 2006

    Pub. L. 109–482 § 103(b)(13)(A) · 120 Stat. 3675

    Struck · 42 U.S.C. § 284l(a)(3)

    Pub. L. 109–482, § 103(b)(13)(A), struck out heading and text of par. (3). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”

    Source evidence

    Code amendment note
    Subsec. (a)(3). Pub. L. 109–482, § 103(b)(13)(A), struck out heading and text of par. (3). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”

    Enacted provision · exact public law section
    (A) paragraph (3) of subsection (a);

    Effective date note
    Amendment by Pub. L. 109–482 applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as a note under section 281 of this title.

  3. National Institutes of Health Reform Act of 2006

    Pub. L. 109–482 § 103(b)(13)(B) · 120 Stat. 3675

    Struck · 42 U.S.C. § 284l(b)(3)

    Pub. L. 109–482, § 103(b)(13)(B), struck out heading and text of par. (3). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”

    Source evidence

    Code amendment note
    Subsec. (b)(3). Pub. L. 109–482, § 103(b)(13)(B), struck out heading and text of par. (3). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”

    Enacted provision · exact public law section
    (B) paragraph (3) of subsection (b);

    Effective date note
    Amendment by Pub. L. 109–482 applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as a note under section 281 of this title.

  4. National Institutes of Health Reform Act of 2006

    Pub. L. 109–482 § 103(b)(13)(C) · 120 Stat. 3675

    Struck · 42 U.S.C. § 284l(c)(5)

    Pub. L. 109–482, § 103(b)(13)(C), struck out heading and text of par. (5). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”

    Source evidence

    Code amendment note
    Subsec. (c)(5). Pub. L. 109–482, § 103(b)(13)(C), struck out heading and text of par. (5). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”

    Enacted provision · exact public law section
    (C) paragraph (5) of subsection (c); and

    Effective date note
    Amendment by Pub. L. 109–482 applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as a note under section 281 of this title.

  5. National Institutes of Health Reform Act of 2006

    Pub. L. 109–482 § 103(b)(13)(D) · 120 Stat. 3675

    Struck · 42 U.S.C. § 284l(d)(4)

    Pub. L. 109–482, § 103(b)(13)(D), struck out heading and text of par. (4). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”

    Source evidence

    Code amendment note
    Subsec. (d)(4). Pub. L. 109–482, § 103(b)(13)(D), struck out heading and text of par. (4). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”

    Enacted provision · exact public law section
    (D) paragraph (4) of subsection (d);

    Effective date note
    Amendment by Pub. L. 109–482 applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as a note under section 281 of this title.

5 of 5 references resolved to an enrolled provision

Editorial Notes

Amendments

2007—Subsec. (a)(3). Pub. L. 109–482, § 103(b)(13)(A), struck out heading and text of par. (3). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”

Subsec. (b)(3). Pub. L. 109–482, § 103(b)(13)(B), struck out heading and text of par. (3). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”

Subsec. (c)(5). Pub. L. 109–482, § 103(b)(13)(C), struck out heading and text of par. (5). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”

Subsec. (d)(4). Pub. L. 109–482, § 103(b)(13)(D), struck out heading and text of par. (4). Text read as follows: “For the purpose of carrying out this subsection, there are authorized to be appropriated such sums as may be necessary for each fiscal year.”

Statutory Notes and Related Subsidiaries

Effective Date of 2007 Amendment

Amendment by Pub. L. 109–482 applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as a note under section 281 of this title.

Credits

1944–2007 · 3 acts
  1. 1944July 1, 1944, ch. 373, title IV, § 409H, formerly § 409D, as added Pub. L. 106–505, title II, § 204(b), , 114 Stat. 2327
  2. 2002renumbered § 409H, Pub. L. 107–109, § 3(2), , 115 Stat. 1408
  3. 2007amended Pub. L. 109–482, title I, § 103(b)(13), , 120 Stat. 3687.
Show as published

(July 1, 1944, ch. 373, title IV, § 409H, formerly § 409D, as added Pub. L. 106–505, title II, § 204(b), , 114 Stat. 2327; renumbered § 409H, Pub. L. 107–109, § 3(2), , 115 Stat. 1408; amended Pub. L. 109–482, title I, § 103(b)(13), , 120 Stat. 3687.)

Parsed from the official OLRC USLM XML in data/usc_all/usc42.xml · release point 119-108 · OLRC build 2026-09-09

USLM identifier /us/usc/t42/s284l